June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Effect of a PG analogue on optic nerve head blood flow in eyes with preperimetric glaucoma
Author Affiliations & Notes
  • Naoki Kiyota
    Tohoku University Hospital, Sendai-shi, Japan
  • Yukihiro Shiga
    Tohoku University Hospital, Sendai-shi, Japan
  • Naoko Aizawa
    Tohoku University Hospital, Sendai-shi, Japan
  • Satoru Tsuda
    Tohoku University Hospital, Sendai-shi, Japan
  • Kazuko Omodaka
    Tohoku University Hospital, Sendai-shi, Japan
  • Tomoki Yasui
    Yasui eye clinic, Rifu, Japan
  • Keiichi Kato
    Kato Eye Center, Taiwa, Japan
  • Toru Nakazawa
    Tohoku University Hospital, Sendai-shi, Japan
  • Footnotes
    Commercial Relationships Naoki Kiyota, Santen Pharmaceutical Co. Ltd (F); Yukihiro Shiga, Santen Pharmaceutical Co. Ltd (F); Naoko Aizawa, Santen Pharmaceutical Co. Ltd (F); Satoru Tsuda, Santen Pharmaceutical Co. Ltd (F); Kazuko Omodaka, Santen Pharmaceutical Co. Ltd (F); Tomoki Yasui, Santen Pharmaceutical Co. Ltd (F); Keiichi Kato, Santen Pharmaceutical Co. Ltd (F); Toru Nakazawa, Santen Pharmaceutical Co. Ltd (F)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 2749. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Naoki Kiyota, Yukihiro Shiga, Naoko Aizawa, Satoru Tsuda, Kazuko Omodaka, Tomoki Yasui, Keiichi Kato, Toru Nakazawa; Effect of a PG analogue on optic nerve head blood flow in eyes with preperimetric glaucoma. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):2749.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To investigate the effect of a prostaglandin (PG) analogue on optic nerve head (ONH) blood flow in eyes with preperimetric (PPG) glaucoma over a 12-month treatment period.

Methods: In this prospective multicenter study, all patients were treated with a topical prostaglandin (PG) analogue. Diagnosis was performed by glaucoma specialists between August 2012 and April 2014. We collected general ophthalmological examination data, and obtained a range of ONH blood flow data with laser speckle flowgraphy (LSFG) in 136 eyes of 136 PPG patients (mean 53.8 ± 14.3 years old) treated with Tafulprost for up to 1 year. Changes in ONH mean blur rate (MBR), a parameter of LSFG that represents relative blood flow, before and 90-120 minutes after the treatment were determined upon enrollment. We defined the patients in the upper quartiles of percentage changes in MBR as high-responders (HRs: 31 eyes) and patients in the lower quartile as low-responders (LRs: 30 eyes). Finally, we compared the prospectively collected follow-up data between the two groups.

Results: There were significantly greater changes in ONH MBR in the HRs than in the LRs both at 4 months and 12 months after the start of treatment (4 months: HRs 5.13 ± 7.87%, LRs -1.52 ± 7.60%, p < 0.001; 12 months: HRs 9.50 ± 6.58%, LRs -2.69 ± 7.95%, p < 0.001). There were no significant differences in intraocular pressure, mean arterial blood pressure, or ocular perfusion pressure between the two study groups. In all patients, the ONH MBR in the pre-instillation period was negatively correlated with changes in ONH MBR at both 4 months and 12 months after the start of treatment (4 months: r = -0.22, p = 0.02; 12 months: r = -0.41, p < 0.001).

Conclusions: HRs in PPG patients showed a steady increase in ONH blood flow over a twelve-month period after the start of PG analogue treatment. Furthermore, our results suggested that patients with lower initial ONH blood flow had a higher possibility to increase ONH blood flow through treatment.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×